India · Delayed Price · Currency is INR Protean eGov Technologies Statistics
Total Valuation
NSE:PROTEAN has a market cap or net worth of INR 28.67 billion. The enterprise value is 26.86 billion.
| Market Cap | 28.67B |
| Enterprise Value | 26.86B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 28, 2026 |
Share Statistics
| Current Share Class | 40.62M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | 4.17% |
| Owned by Institutions (%) | 27.77% |
| Float | 38.32M |
Valuation Ratios
The trailing PE ratio is 38.28 and the forward PE ratio is 25.11.
| PE Ratio | 38.28 |
| Forward PE | 25.11 |
| PS Ratio | 2.75 |
| PB Ratio | 2.71 |
| P/TBV Ratio | 2.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 26.24 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.96 |
| EV / Sales | 2.57 |
| EV / EBITDA | 32.20 |
| EV / EBIT | 50.37 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.92 |
| Quick Ratio | 1.76 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 1.52 |
| Debt / FCF | n/a |
| Interest Coverage | 5.72 |
Financial Efficiency
Return on equity (ROE) is 7.22% and return on invested capital (ROIC) is 4.94%.
| Return on Equity (ROE) | 7.22% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 4.94% |
| Return on Capital Employed (ROCE) | 4.52% |
| Weighted Average Cost of Capital (WACC) | 5.35% |
| Revenue Per Employee | 12.51M |
| Profits Per Employee | 895,590 |
| Employee Count | 839 |
| Asset Turnover | 0.74 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:PROTEAN has paid 195.90 million in taxes.
| Income Tax | 195.90M |
| Effective Tax Rate | 20.68% |
Stock Price Statistics
The stock price has decreased by -16.34% in the last 52 weeks. The beta is 0.20, so NSE:PROTEAN's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -16.34% |
| 50-Day Moving Average | 601.00 |
| 200-Day Moving Average | 583.28 |
| Relative Strength Index (RSI) | 66.12 |
| Average Volume (20 Days) | 400,985 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:PROTEAN had revenue of INR 10.50 billion and earned 751.40 million in profits. Earnings per share was 18.46.
| Revenue | 10.50B |
| Gross Profit | 7.53B |
| Operating Income | 536.40M |
| Pretax Income | 947.30M |
| Net Income | 751.40M |
| EBITDA | 839.10M |
| EBIT | 536.40M |
| Earnings Per Share (EPS) | 18.46 |
Balance Sheet
The company has 3.09 billion in cash and 1.28 billion in debt, with a net cash position of 1.82 billion.
| Cash & Cash Equivalents | 3.09B |
| Total Debt | 1.28B |
| Net Cash | 1.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.63B |
| Book Value Per Share | 261.94 |
| Working Capital | 3.02B |
Cash Flow
In the last 12 months, operating cash flow was 1.10 billion and capital expenditures -1.34 billion, giving a free cash flow of -239.80 million.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -1.34B |
| Depreciation & Amortization | 302.70M |
| Net Borrowing | -185.20M |
| Free Cash Flow | -239.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 71.72%, with operating and profit margins of 5.11% and 7.16%.
| Gross Margin | 71.72% |
| Operating Margin | 5.11% |
| Pretax Margin | 9.03% |
| Profit Margin | 7.16% |
| EBITDA Margin | 8.00% |
| EBIT Margin | 5.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 1.42%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 1.42% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.17% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.27% |
| Shareholder Yield | 1.68% |
| Earnings Yield | 2.61% |
| FCF Yield | -0.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:PROTEAN is 727.50, which is 2.96% higher than the current price. The consensus rating is "Buy".
| Price Target | 727.50 |
| Price Target Difference | 2.96% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |